Navigation Links
GeneNews' Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
Date:8/29/2007

- Text provides cardiologists with an overview of cardiovascular genetics

and genomics -

TORONTO, Aug. 29 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing patient-friendly blood-based biomarker tests for the detection and staging of virtually any disease or medical condition, today announced that its co-founder and Chief Scientist Dr. C.C. Liew, has co-edited a newly published genomics reference book entitled Cardiovascular Genetics and Genomics for the Cardiologist. The text provides cardiologists with an overview of cardiovascular genetics and genomics, which have been changing the fundamental understanding of cardiovascular disease and the practice of cardiovascular medicine.

"We are very proud of our Chief Scientist and the inventor of our core technologies, Dr. C.C. Liew. This is not only a significant achievement for Dr. Liew, but also an important and notable contribution to both the field of disease-specific genomics and the field of cardiovascular medicine," said K. Wayne Marshall, MD, PhD, President and Chief Executive Officer of GeneNews. "Dr. Liew is truly a pioneer in disease-specific genomics and has earned a global reputation for his outstanding scientific contributions in this cutting-edge area of healthscience."

Dr. Liew currently holds the positions of Visiting Professor of Medicine and Founding Director of the Cardiovascular Genome Unit at Brigham and Women's Hospital, Harvard Medical School, and Professor Emeritus at the University of Toronto. Genetics and Genomics for the Cardiologist is currently available from the publisher, Blackwell Publishing Inc. (http://www.blackwellcardiology.com).

About GeneNews

--------------

GeneNews is focused on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle(TM) in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews' first product in development, ColonSentry(TM), is a convenient and patient-friendly blood-based biomarker test that can detect colon cancer. For more information on GeneNews, visit http://www.genenews.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE GeneNews Limited
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. State technology chief endorses IT audit recommendations
2. Fusion 2007: CA chief says IT complexity raises risk
3. Web-Based Learning Developed under new Chief Education Officer
4. UW computer scientists fighting computer virus "Cold War"
5. UW scientist, former WiCell director found stem cell company
6. Scientists find way to make human collagen in lab
7. Wisconsin scientists to be recognized for innovative biofuel technology
8. UW biophysical scientist honored as society fellow
9. UW scientist wins Pew grant to study little-known immune cells
10. UW-Madison scientists to mimic nature for newest cancer drugs
11. The Scientist magazine names Madison "hotspot" for biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... The medical potential of stem cells is both ... of medicine, due to their differentiating characteristics. Stem cells are unique as the have ... be induced to become tissue or organic-specific cells with special functions. , Stem ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... cell therapy manufacturing facility at its headquarters laboratory in Poway, California. Based ... the experience of both in-house personnel and consultants, VetStem constructed and validated a ...
(Date:2/21/2017)... and VANCOUVER, British Columbia , ... OGXI ) today announced that apatorsen results from two randomized ... of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium, held February ... . Clinical data from trials in bladder and prostate ... administered in combination with standard-of-care treatments. ...
(Date:2/21/2017)... --  Logicalis Healthcare Solutions , the healthcare-focused practice within ... provider ( www.us.logicalis.com ), today announced a new service ... service will help hospital CIOs make the best use ... and other clinicians immediate access to a pool of ... hospital IT staff to focus on broader issues such ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... 2017 About Voice Recognition Biometrics Voice recognition ... against a stored voiceprint template. Acoustic features of ... tone are compared to distinguish between individual voices. ... most PCs already have a microphone and can ... biometrics are most likely to be deployed in ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
Breaking Biology News(10 mins):